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Abstract
Background: Prolonged psychosocial stress is a condition assessed through self-reports. Here we aimed to identify
biochemical markers for screening and early intervention in women.
Methods: Plasma concentrations of interleukin (IL) 1-a, IL1-b, IL-2, IL-4, IL-6, IL-8, IL-10, interferon-c (INF-c), tumor necrosis
factor-a (TNF-a), monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF), vascular endothelial growth
factor (VEGF), thyroid stimulating hormone (TSH), total tri-iodothyronine (TT3), total thyroxine (TT4), prolactin, and
testosterone were measured in: 195 women on long-term sick-leave for a stress-related affective disorder, 45 women at risk
for professional burnout, and 84 healthy women.
Results: We found significantly increased levels of MCP-1, VEGF and EGF in women exposed to prolonged psychosocial
stress. Statistical analysis indicates that they independently associate with a significant risk for being classified as ill.
Conclusions: MCP-1, EGF, and VEGF are potential markers for screening and early intervention in women under prolonged
psychosocial stress.
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Introduction
Sustained psychosocial stress, often related to work, is an
increasingly important factor in the development of illness,
physical as well as mental [1–3]. In Sweden, public expenditure
for sick-leave more than doubled in a few years, and in 2003 the
number of workers on long-term sick-leave (more than 30 days)
increased to all time high levels [4]. Women represent about 70–
80% of this patient group. We have studied more than 400
patients on long-term sick leave because of an affective disorder,
and found that about 80% met DSM-IV criteria for major
depression at some time during their illness (our unpublished data).
However, mental and physical exhaustion were the most
prominent symptoms, which tended to persist after the depressive
symptoms had cleared. Many patients remained incapacitated for
a very long period with a pronounced tendency to recurrence.
The sequence of pathophysiological events set forward by
prolonged exposure to mental stress in humans is not completely
characterized, but it involves the hypothalamus-pituitary-adrenal
(HPA) axis, as well as the endocrine and the immune systems [5–
7]. The cortisol response to corticotropin-releasing hormone
(CRH) was recently analyzed in our patients [8]. The results
showed an attenuated dexamethasone-CRH response, a feature
opposite to that seen in other patients with major depression [9].
Such a finding suggests an imbalance in other physiological
systems. Metabolic processes occurring under chronic stress might
be reflected in altered hormones, cytokines and cellular growth
factors levels [10–11].
Here, we have taken advantage of the microarray technology,
which uses miniaturized microspot ligand-binding assays to enable
the simultaneous measurement of a large number of biochemical
markers from a minute plasma sample within a single assay [12].
Using this technique we assessed a panel of 17 biological mediators
(hormones, cytokines, and cellular growth factors), aiming to
investigate whether plasma concentrations of any of these
molecules could be related to prolonged psychosocial stress, and
if so, whether they could be used, individually or in combination,
as markers for screening and diagnostic purposes.
Materials and Methods
Patients on long term sick leave
The studies were cleared by the Research Ethics Committees of
the Karolinska Institute, and the Medical Faculty of Linko ¨ping
University, respectively. One hundred ninety-five women (mean
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sickleave (more than three months) for any affective or stress-
related mental disorder (depression, anxiety disorder, stress
disorder, burnout syndrome, exhaustion disorder) were recruited
from one of the major Swedish insurance companies, the Alecta
Company, which insures about 600,000 employees in private
enterprises, mainly white collar workers. The company keeps a
database which includes diagnostic information for all cases of sick
leave exceeding 3 months. Letters were sent to all patients on sick
leave with any of the above mentioned diagnoses on their sickness
certificate. Patients were then approached by telephone and
invited to participate in a clinical study involving interviews and
questionnaires, as well as an offer of further treatment. Written
informed consent was obtained from all participants. All patients
were ambulatory and none had received inpatient care for their
current illness. They were diagnosed according to the Diagnostic
and Statistical Manual of the American Psychiatric Association,
4th Edition [DSM-IV; 13] by specially trained physicians, using
the Structured Clinical Interview for DSM-IV [14]. Eighty-two
per cent met DSM-IV criteria for Major Depressive Disorder at
some time during their current illness episode. Likely eliciting
factors were: work-related stress (39%), stressful family relation-
ships (9.3%), a combination of work and family stressors (49.3%),
or not identified (2.1%).
Health care personnel with occupational stress
A group of women experiencing work stress was selected from
the results of a questionnaire sent to all 6118 health care
employees of a Swedish county council (Kalmar). Of the 3976
employees who replied to the questionnaire, those who scored
above the 75th percentile on the Oldenburg Burnout Inventory
[OLBI; 15], which measures degree of professional burnout, were
invited to participate in a randomized controlled study of the
possible beneficial effect of a series of structured group discussions
with colleagues. Those who were randomised to active treatment
were asked to leave blood samples prior to treatment. The
resulting group consisted of 45 women, ranging in age from 39 to
62 years, mean age 52.8, SD=5.2 years.
Healthy control workers
The control group included 84 women (mean age 36.1,
SD=8.4, range 23–62 years), recruited among the employees of
a Swedish IT-company. Out of 560 employees, both women and
men, the above 84 individuals had agreed to undergo a
physiological examination as part of a health screening in a stress
prevention program at the company. The subjects were all full
time workers, of whom 34% were managers and 54% project
leaders. Two women who were pregnant at the time of the
physiological examination were excluded.
Analytical methods
Venous blood was drawn into tubes containing EDTA, and
immediately centrifuged. Plasma was separated and stored in
aliquots at 220uC or below until analyzed. The following
cytokines and growth factors were analyzed: interleukin 1-a
(IL1-a), interleukin 1-b (IL1-b), interleukin 2 (IL-2), interleukin 4
(IL-4), interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 10 (IL-
10), interferon-c (INF-c), tumor necrosis factor-a (TNF-a),
monocyte chemotactic protein-1 (MCP-1), epidermal growth
factor (EGF), and vascular endothelial growth factor (VEGF).
Furthermore, thyroid stimulating hormone (TSH), total tri-
iodothyronine (TT3), total thyroxine (TT4), prolactin, and
testosterone were included in the panel analyzed on a high
throughput automated biochip immunoassay system, EvidenceH,
Randox Laboratories Ltd [Crumlin, UK; 16]
Statistical analysis
All analyses were performed with the SPSS 11.5 for Windows.
One-way ANOVA’s were calculated by using the group variable
as independent variable with 3 levels, and each biochemical
marker as a dependent variable. The significance levels were
adjusted according to Bonferroni’s method. Pair-wise post hoc
comparisons were made according to Scheffe’s method. To
determine the optimal cut-off point maximizing the sensitivity
(true positive rate) and specificity (true negative rate), receiver
operating curve (ROC) analyses were performed [17]. An area
under the ROC curve of 0.9 or above is needed for a reliable
differentiation of the groups. To calculate the odds of being
classified as ill or not, when having a value above, compared with
below the established cut-off, logistic regression analyses were
used.
Results
Means and standard deviations for the 17 markers in the three
groups are shown in Tables 1 and 2. Neither the interleukins nor
IFN-c or TNF-a differed between the groups. Differences were
observed, however, between the three subject groups for MCP-1,
EGF, and VEGF. MCP-1 levels were more than twice as high in
the sick leave group compared to the healthy controls, with the
occupational stress group in between. VEGF levels were three
times as high in the sick leave group, and EGF levels were more
than twice as high, compared to the healthy group, once again
with the occupational stress group in between. The sick leave
group also had significantly lower levels of prolactin and TSH
(Table 1).
Since the correlations between some of the markers and age
were significant, and the mean age differed significantly between
the groups (one-way ANOVA F=59.09 df=2,338, P=0.000), we
controlled for age in an analysis of covariance. This resulted in one
additional significant difference, namely in testosterone, which was
higher in the sick leave group. In order to examine the usefulness
of these markers for screening and diagnostic purposes, a receiver
operating characteristic (ROC) curve analysis was performed
(Table 2). As seen from the table, the best sensitivity and specificity
was obtained for MCP-1, VEGF, and EGF.
The relative value of MCP-1, EGF, and VEGF as risk factors
for classification as ill or healthy was also tested. The results are
shown in Table 3, and indicate that each of these markers
independently associates with a significantly increased risk for
being classified as ill.
Discussion
Our results show a direct correlation between plasma
concentrations of MCP-1, EGF, and VEGF, and psychosocial
stress-related illness. Plasma levels were elevated in subjects with
occupational stress, and more so in a group of subjects on long
term sick leave for an affective disorder following exposure to
chronic stress. Statistically, each of these three markers associated
independently with a significantly increased risk for being classified
as ill.
However, our results should be seen as preliminary, and need to
be replicated because of a number of intrinsic limitations:
(i) The study design has involved only one single time point
observation during the course of a prolonged stress
condition. This design may in principle suffer from possible
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an almost complete 2-year follow up study on our recovering
patient cohort, showing that MCP-1, EGF, and VEGF in
plasma decrease very slowly within months to years (A ˚sberg
et al, unpublished).
(ii) The daytime point for blood withdrawal varied among
individuals approximately between 9 AM and 3 PM, making
circadian rhythm a possible confounding factor. Circadian
rhythms have been described for EGF and VEGF, and
MCP-1 [18,19,20]. However, both EGF and VEGF plasma
levels are relatively stable during daytime [21,22]. Thus, it is
unlikely that collection time points could significantly
influence results on these two mediators. On the other
hand, the studies available on MCP-1 were done in mice
peritoneal macrophages [20], and to our knowledge similar
studies have not been confirmed in any human tissue. Thus,
it remains entirely possible that collection time points may
have played a role for MCP-1, as well as for other markers
for which we have not found a significant association with
stress and disease. Indeed, several of these markers are
known to have circadian rhythms [23], and for this reason
our negative results should be taken with caution.
(iii) We have not controlled for nicotine consumption or for sex
hormone variables such as menstrual phase or oral
contraceptive use. Also, data on nutrition and physical
activity have not been consistently collected across groups.
While our study is mainly concerned with their potential use as
markers of disease, plasma MCP-1, EGF, and VEGF may also be
related to pathophysiological outcomes that are worth to consider.
For instance, MCP-1 mediates inflammatory-like disorders and
oxidative stress [24], and it also contributes to macrophage
infiltration into adipose tissue and insulin resistance [25].
Moreover, at least for acute stress there are examples of an
MCP-1 effect on chemotaxis and immune cell redistribution.
Table 1. Biochemical markers in women experiencing different levels of stress.
Marker
Sick leave
(group 1)
Occupational stress
(group 2)
Healthy Subjects
(group 3) ANOVA
Significant group pair
wise comparisons
M SD M SD M SD F Df P
IL1-a 5.1 14.1 5.6 6.1 5.4 5.1 0.92 2,338 .402
IL1-b 2.9 6.4 2.5 4.0 2.1 2.7 0.59 2,338 .554
IL-2 17.6 39.4 18.6 24.0 14.6 24.0 0.31 2,338 .734
IL-4 3.8 3.5 3.2 0.8 3.3 1.7 1.82 2,338 .163
IL-6 6.6 16.4 9.4 26.2 13.7 33.4 2.87 2,333 .058
IL-8 5.4 10.8 3.3 2.9 3.1 1.3 2.98 2,338 .052
IL-10 3.4 6.6 3.0 5.6 6.5 20.3 2.37 2,338 .095
IFN-c 0.7 0.7 0.7 0.7 0.7 0.7 0.39 2,338 .678
TNF-a 5.1 16.2 3.3 2.5 5.3 19.6 0.26 2,338 .773
MCP-1 348.4 126.7 217.8 92.6 160.2 85.7 97.82 2,338 .000* 1–2, 1–3, 2–3
EGF 117.0 77.2 70.6 53.0 29.4 47.5 56.16 2,338 .000* 1–2, 1–3, 2–3
VEGF 30.9 22.7 18.4 15.4 10.3 7.1 41.24 2,338 .000* 1–2, 1–3
Prolactin 388.6 216.4 534.0 246.3 684.1 748.0 15.47 2,346 .000* 1–3
TT3 0.5 0.3 0.6 0.2 0.5 0.3 6.46 2,329 .002* 1–2
TT4 6.9 1.6 7.1 1.6 7.2 1.8 0.82 2,441 .442
TSH 1.8 1.0 2.4 1.6 2.4 1.2 11.11 2,342 .000* 1–3
Testosterone 4.1 1.5 4.0 1.8 3.5 1.4 5.39 2,330 .005
Concentration is given in pg/ml except for prolactin (mIU/L), TT3 (ng/ml), TT4 (g/L), and TSH (mIU/ml), and testosterone (nmol/L). Mean (M) and standard deviation (SD)
values are indicated for the three test groups. Significant comparisons between groups (P,.05 level) are indicated in the last column.
doi:10.1371/journal.pone.0003590.t001
Table 2. Optimal cut-off, area under the ROC-curve (Area),
and diagnostic sensitivity and specificity of statistically
significant biochemical markers.
Marker Area Cut-off Sensitivity Specificity
MCP-1 0.886 243.00 0.85 0.92
VEGF 0.805 7.80 0.78 0.85
EGF 0.798 68.00 0.69 1.00
Prolactin 0.699 380.00 0.60 0.79
TSH 0.624 1.80 0.58 0.69
Testosterone 0.618 3.73 0.63 0.65
doi:10.1371/journal.pone.0003590.t002
Table 3. Relative risks of being classified as ill, using the
established cut-off points of MCP-1, EGF and VEGF (Table 3).
Marker Beta Wald P OR 95% CI
MCP-1 3.55 52.17 0.000 34.85 13.30–91.35
EGF 2.12 18.02 0.000 8.35 3.13–22.25
VEGF 2.08 18.99 0.000 8.02 3.14–20.44
Results from multiple logistic regression analyses are shown. OR, Observed Risk,
(95% CI).
doi:10.1371/journal.pone.0003590.t003
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atherosclerosis. [26]. On the other hand, EGF is a mediator of
stress-related events influencing the cell cycle [27]. This might be
particularly important in heart diseases, where adverse effects of
angiotensin II could be partly mediated by EGF [28]. Similarly,
VEGF has been reported to be upregulated by angiotensin II, and
thereby activate vascular inflammation [29]. However, VEGF has
also been reported to act as a neuroprotective factor, which makes
our results somewhat intriguing [30]. Also, VEGF has recently
been shown to selectively recruit stem and progenitor cells to
specific organs [31].
While psychosocial stress in humans is a complex phenomenon
not readily captured by bodily biochemical modifications, animal
models have began to shed light on translational mediating events.
In mice, psychosocial stress has been shown to be converted into
cell cycle signalling, and the mechanism is mediated by the
transcription factor nuclear factor kappaB [NF-kappaB; 32].
Interestingly, NF-kappaB expression in humans has been reported
to be influenced by EGF and VEGF during various pathological
conditions [33,34]. In turn, MCP-1 expression has been shown to
be controlled by NF-kappaB [35]. Taken together, these data
suggest that psychosocial stress may broadly influence pathophys-
iological changes acting on a cellular level also in humans.
Previous studies have shown that patients on sick leave because
of occupational burnout resulting from psychosocial stress, have a
disrupted sleep, with more arousals and sleep fragmentation, more
wake time, and lower sleep efficiency [36]. Sleep fragmentation is
associated with elevated levels of metabolic and cardiovascular risk
indicators of stress-related disorders, such as morning cortisol,
heart rate, systolic and diastolic blood pressure, total cholesterol,
high-density lipoprotein (HDL)- and low-density lipoprotein
(LDL)-cholesterol, and LDL/HDL-ratio [37]. It is conceivable
that some of the pathophysiological changes developing during
exposure to psychosocial chronic stress reflect sleep disturbances.
Some studies suggest that MCP1, EGF en VEGF levels may
indeed be related with sleep quality, and be altered as an effect of
disrupted sleep [38–40]. It would be therefore important to test a
correlation of MCP1, EGF and VEGF levels in relationship to
qualitative and quantitative sleep alterations.
Taken together with the recently reported dexamethasone-
CRH data [8], our results indicate that women under prolonged
psychosocial stress develop so-far unique neuro-endocrine-im-
mune alterations. If confirmed, our results may be developed into
novel work hypotheses to construct models for further investiga-
tions both in the preclinical and in the clinical settings. Also, our
data may bring to the clinician a potential tool for diagnosis of a
condition that is poorly understood, not diagnosable through
laboratory tests, yet progressively more common in industrialized
areas of the word.
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